Ameya Agge is a Managing Director on the Healthcare Investing team and a member of the Healthcare Investment Committee. Prior to joining AHP and BlueMountain, Mr. Agge was a Partner at Apax Partners where he invested across healthcare segments in the U.S. and Europe. During his 11 years at Apax Partners, Mr. Agge served on the boards of KEPRO, Ideal Protein, Genex, One Call Care Management, Dune, Unilabs, and General Healthcare Group. Mr. Agge received a Bachelor’s degree in Technology from the India Institute of Technology in Bombay, a M.S. in Chemical Engineering from M.I.T., and a M.B.A. in Health Care Management from The Wharton School at the University of Pennsylvania.